Crinetics | SC 13G/A:超过5%持股股东披露文件(修正)-Point72 Asset Management, L.P.(2.9%),Point72 Capital Advisors, Inc.(2.9%)等
Crinetics | SC 13G/A:超过5%持股股东披露文件(修正)-EcoR1 Capital, LLC(4.8%),Oleg Nodelman(4.8%)等
Crinetics | SC 13G:超过5%持股股东披露文件-T. ROWE PRICE ASSOCIATES, INC.(6.2%)
Crinetics | 10-Q:2024财年三季报
Crinetics | 8-K:Crinetics Pharmicals公布2024年第三季度财务业绩并提供业务最新情况
Crinetics | SC 13G/A:超过5%持股股东披露文件(修正)-The Vanguard Group(7.85%)
Crinetics | SC 13G:超过5%持股股东披露文件-Wellington Management Group LLP(5.57%),Wellington Group Holdings LLP(5.57%)等
Crinetics | SC 13G/A:超过5%持股股东披露文件(修正)-The Vanguard Group(7.85%)
Crinetics | SC 13G/A:超过5%持股股东披露文件(修正)-STATE STREET CORPORATION :(3.6%)
Crinetics | 8-K:重大事件
Crinetics | 8-K:重大事件
Crinetics | 424B5:募资说明书
Crinetics | 424B5:募资说明书
Crinetics | 4:持股变动声明-高管 Pizzuti Dana
Crinetics | 144:拟议出售证券
Crinetics | 4:持股变动声明-高管 Wilson Marc
Crinetics | 8-K:重大事件
Crinetics | 144:拟议出售证券
Crinetics | 8-K:重大事件
Crinetics | 4:持股变动声明-高管 Betz Stephen F.
暂无数据
暂无数据